Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary May 2005 The Evangelizing Patient, Commentary 1 J. Wesley Boyd, MD, PhD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary May 2005 The Evangelizing Patient, Commentary 2 John Dunlop, MD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary May 2005 The Evangelizing Patient, Commentary 3 Harold G. Koenig, MD, MHSc Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Oct 2023 How to Draw on Narrative to Mitigate Ageism William Smith, MD, MBA, MPH, David Elkin, MD, MSL, and Art Walaszek, MD Ageism is so structurally integrated and normalized in US health care that it is generally unnoticed by many clinicians. AMA J Ethics. 2023;25(10):E745-750. doi: 10.1001/amajethics.2023.745.
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 1 J. Wesley Boyd, MD, PhD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 2 John Dunlop, MD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 3 Harold G. Koenig, MD, MHSc Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Oct 2023 How to Draw on Narrative to Mitigate Ageism William Smith, MD, MBA, MPH, David Elkin, MD, MSL, and Art Walaszek, MD Ageism is so structurally integrated and normalized in US health care that it is generally unnoticed by many clinicians. AMA J Ethics. 2023;25(10):E745-750. doi: 10.1001/amajethics.2023.745.